Specifically, the PI3K-Akt Pathway (of which AKT1 is part) is part of altered insulin signaling in AD brains [84] and a target for the prevention and treatment of AD [85]; strong Akt immunoreactivity was seen in AD pyramidal neurons likely undergoing degeneration and in reactive astroglia [86]. The gene discussed is AKT1; the disease is Alzheimer disease.